Anti-CD83 antibody [EPR22405]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(3 Publications)
Rabbit Recombinant Monoclonal CD83 antibody. Suitable for Flow Cyt, WB, ICC/IF and reacts with Human samples. Cited in 3 publications.
View Alternative Names
CD83, CD83 antigen, hCD83, B-cell activation protein, Cell surface protein HB15
- Flow Cyt
Unknown
Flow Cytometry - Anti-CD83 antibody [EPR22405] (AB244204)
Flow cytometric analysis of HDLM-2 (human Hodgkin lymphoma) cell line labeling CD83 with ab244204 at 1/50 (red) compared with a Rabbit monoclonal IgG (ab172730) (black) and an unlabeled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077), at 1/2000 dilution was used as the secondary antibody.
Gated on viable cells.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-CD83 antibody [EPR22405] (AB244204)
Immunofluorescent analysis of HDLM-2 (human Hodgkin lymphoma) cells fixed with 100% methanol, labeling CD83 with ab244204 at 1/50 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing membranous and cytoplasmic staining in HDLM-2 cells is observed. We recommend using methanol instead of PFA fixation. The nuclear counter stain is DAPI (blue).
Counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) at a 1/200 dilution (red).
The negative control is the secondary antibody only.
- Flow Cyt
Unknown
Flow Cytometry - Anti-CD83 antibody [EPR22405] (AB244204)
Flow cytometric analysis of human peripheral blood mononuclear cell (PBMC) labeling CD83 with ab244204 at 1/50 (Right panel) compared with a Rabbit monoclonal IgG (ab172730) (Left panel). Goat anti rabbit IgG (Dylight® 488, ab98462), at 1/2000 dilution was used as the secondary antibody.
Cells were stained with rabbit IgG (Left panel) or anti-CD83 RabMab (Right panel). Then stained with Alexa Fluor® 647-conjugated anti-CD14. The result is consistent with what has been described in the literature. (PMID : 15320871).
Gated on viable cells.
- WB
Unknown
Western blot - Anti-CD83 antibody [EPR22405] (AB244204)
The molecular weight observed is consistent with what has been described in the literature (PMID : 15320871). The bands above 23 kDa are glycosylated forms.
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : 3 minutes.
All lanes:
Western blot - Anti-CD83 antibody [EPR22405] (ab244204) at 1/1000 dilution
Lane 1:
Untreated THP-1 (human monocytic leukemia monocyte) whole cell lysate at 10 µg
Lane 2:
THP-1 treated with 100ng/ml LPS for 3 hours, whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 23 kDa
false
- WB
Unknown
Western blot - Anti-CD83 antibody [EPR22405] (AB244204)
The molecular weight observed is consistent with what has been described in the literature (PMID : 15320871). The bands above 23 kDa are glycosylated forms.
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : 26 seconds.
All lanes:
Western blot - Anti-CD83 antibody [EPR22405] (ab244204) at 1/1000 dilution
Lane 1:
Untreated Raji (human burkitt's lymphoma b lymphocyte) whole cell lysate at 20 µg
Lane 2:
Raji whole cell lysate treated with PNGase F at 20 µg
Lane 3:
Untreated HDLM-2 (human hodgkin lymphoma) whole cell lysate at 20 µg
Lane 4:
HDLM-2 whole cell lysate treated with PNGase F at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 23 kDa
Observed band size: 40-50 kDa
false
Related conjugates and formulations (1)
-
Anti-CD83 antibody [EPR22405] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The primary role of CD83 involves the regulation of immune responses. It functions by modulating the activity and communication of immune cells especially impacting the antigen-presenting capabilities of dendritic cells. CD83 also plays a role in promoting the maturation of these cells and influencing T-cell responses. Although CD83 is not generally recognized as a part of a complex its interactions with other cell surface molecules are significant for immune system function.
Pathways
CD83 has notable involvement in immune signaling pathways including the NF-kB and JAK/STAT pathways. These pathways are critical for transmitting signals that influence cell survival proliferation and activation. Through these pathways CD83 interacts with proteins such as cytokines and growth factors which further modulate their effects on immune cells and their responses.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in pharmacology 16:1503971 PubMed40206088
2025
Applications
Unspecified application
Species
Unspecified reactive species
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 12:e2412282 PubMed39887620
2025
Applications
Unspecified application
Species
Unspecified reactive species
Arteriosclerosis, thrombosis, and vascular biology 44:1628-1645 PubMed38813696
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com